Prestige Biologics Statistics

Total Valuation

KOSDAQ:334970 has a market cap or net worth of KRW 343.73 billion. The enterprise value is 417.24 billion.

Market Cap	343.73B
Enterprise Value	417.24B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:334970 has 77.42 million shares outstanding. The number of shares has increased by 19.02% in one year.

Current Share Class	n/a
Shares Outstanding	77.42M
Shares Change (YoY)	+19.02%
Shares Change (QoQ)	+23.39%
Owned by Insiders (%)	20.27%
Owned by Institutions (%)	0.02%
Float	27.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	75.40
PB Ratio	2.43
P/TBV Ratio	2.45
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-10.11
EV / Sales	107.84
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-17.19

Financial Position

The company has a current ratio of 0.55, with a Debt / Equity ratio of 0.63.

Current Ratio	0.55
Quick Ratio	0.18
Debt / Equity	0.63
Debt / EBITDA	n/a
Debt / FCF	-3.69
Interest Coverage	-3.06

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-20.20%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +9.03% in the last 52 weeks. The beta is 1.09, so KOSDAQ:334970's price volatility has been similar to the market average.

Beta (5Y)	1.09
52-Week Price Change	+9.03%
50-Day Moving Average	4,864.90
200-Day Moving Average	5,210.65
Relative Strength Index (RSI)	37.85
Average Volume (20 Days)	124,692

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:334970 had revenue of KRW 3.87 billion and -41.26 billion in losses. Loss per share was -627.97.

Revenue	3.87B
Gross Profit	-20.66B
Operating Income	-36.20B
Pretax Income	-41.26B
Net Income	-41.26B
EBITDA	-23.18B
EBIT	-36.20B
Loss Per Share	-627.97

Full Income Statement

Balance Sheet

The company has 16.05 billion in cash and 89.56 billion in debt, giving a net cash position of -73.51 billion or -949.47 per share.

Cash & Cash Equivalents	16.05B
Total Debt	89.56B
Net Cash	-73.51B
Net Cash Per Share	-949.47
Equity (Book Value)	141.11B
Book Value Per Share	1,823.56
Working Capital	-51.22B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -17.52 billion and capital expenditures -6.75 billion, giving a free cash flow of -24.27 billion.

Operating Cash Flow	-17.52B
Capital Expenditures	-6.75B
Free Cash Flow	-24.27B
FCF Per Share	-313.51

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-935.70%
Pretax Margin	-1,066.36%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KOSDAQ:334970 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.02%
Shareholder Yield	-19.02%
Earnings Yield	-12.00%
FCF Yield	-7.06%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KOSDAQ:334970 has an Altman Z-Score of -0.46. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.46
Piotroski F-Score	n/a